Israeli Drug Company Donating Millions of Malaria Pills to U.S.


Israeli pharmaceutical company Teva is donating millions of doses of a malaria drug that is believed to be effective in fighting the symptoms of the coronavirus.

The Jerusalem Post reports that the six million doses of hydroxychloroquine sulfate will be shipped to US hospitals started March 31. By the end of next month, 10 million will be shipped.

It is uncertain how effective the malaria treatment will be against coronavirus, but research is currently ongoing.

Brendan O’Grady, Teva Executive Vice President, North America Commercial, said, “We are committed to helping to supply as many tablets as possible as demand for this treatment accelerates at no cost.”

“Immediately upon learning of the potential benefit of hydroxychloroquine, Teva began to assess supply and to urgently acquire additional ingredients to make more product while arranging for all of what we had to be distributed immediately,” he stated.

Email to a friend, Share on Facebook, Share on Twitter, and more:

Click here to return to World Jewish Daily

about              subscribe to wjd morning update              questions or comments about this site?